Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy.
Niemann J, Woller N, Brooks J, Fleischmann-Mundt B, Martin NT, Kloos A, Knocke S, Ernst AM, Manns MP, Kubicka S, Wirth TC, Gerardy-Schahn R, Kühnel F.
Niemann J, et al. Among authors: manns mp.
Nat Commun. 2019 Jul 19;10(1):3236. doi: 10.1038/s41467-019-11137-5.
Nat Commun. 2019.
PMID: 31324774
Free PMC article.